Glenmark Life Sciences standalone net profit declines 19.72% in the September 2024 quarter

Net profit of Glenmark Life Sciences declined 19.72% to Rs 95.32 crore in the quarter ended September 2024 as against Rs 118.74 crore during the previous quarter ended September 2023. Sales declined 14.86% to Rs 506.88 crore in the quarter ended September 2024 as against Rs 595.36 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	506.88	595.36	-15
OPM %	26.51	28.07	-
PBDT	142.55	172.06	-17
PBT	127.46	158.93	-20
NP	95.32	118.74	-20